Aspen Aerogels (NYSE: ASPN) reported Q4 EPS of ($0.04), $0.11 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $23 million versus the consensus estimate of $26.75 million.

For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.